Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2020-10-01
Collection:Pharmaceuticals
Sujets:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Accès en ligne:https://www.mdpi.com/1424-8247/13/10/324
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires